Navigation Links
Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
Date:5/17/2010

hima"). Zushima is a traditional Chinese herbal product used to relieve pain through a topical application of the medicine to affected areas or closed wounds. Zushima spray can also be used in the treatment of certain rheumatic conditions. The product was classified as "Specially Needed Drug" by the Chinese Military Drug Administration and will also be available to the public.

On March 29, 2010, Biostar officially took control over the assets of Xi'an Mei pude Bio-Technology Co., Ltd., a Xi'an-based medical equipment and nutrients manufacturer ("Meipude"). Biostar is working on a production marketing program and anticipates starting sales using the acquired assets in May 2010.

Conference Call

The Company will host a conference call to discuss the 2010 first quarter financial results on Monday, May 17, 2010 at 9:30 a.m. ET. Interested participants should call +1-877-941-4775 within the United States, or US +1- 480-629-9763 if calling internationally. The conference ID is 4302147. It is advisable to dial in approximately 5-10 minutes prior to 9:30 a.m. ET. This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at http://www.viavid.net or at the following link: http://viavid.net/dc
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
2. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
3. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
4. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
5. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
7. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
8. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
9. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
10. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
11. Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015 The Dohmen Company today announced ... MBA as Chief Science Officer (CSO) of Dohmen ... role, Dr. Floyd will lead Dohmen,s growing regulatory ... pre-commercial and post approval outsourced services in quality, ... Dr. Floyd brings decades of experience leading global ...
(Date:9/1/2015)... 1, 2015   Medfusion, Inc., a ... between doctors and patients, today announced a $3 ... -based venture capital firms.   ... with Bull City Venture Partners and Hatteras Venture ... and Executive Chairman. "Both firms, experience working at ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... University of California Los Angeles, Boston University School of Medicine, Frederick National Laboratory ... PLOS One, the world’s first multidisciplinary Open Access journal. , Christopher Ryan ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Global Supply Chain ... management and resiliency practitioners with luminaries and thought leaders to advance the professional ... for their innovations and performance excellence. At that time its principle sponsor, ...
Breaking Biology Technology:Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 3Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 3
... During July 2003, two British education officals visited ... be exported. At a time when many Wisconsin ... other cities and regions, it is ironic that ... the same challenges and have turned to Wisconsin ...
... regulatory approvals for the $2.3 billion acquisition of Instrumentarium ... of two divisions of the company they are acquiring. ... plans to integrate Instrumentarium it into its GE ... Dow Wilson.. , ,The final required regulatory ...
... open a new state-of-art healthcare facility in October, 2003. ... in digital imaging technology from technology vendor Emageon. Both ... distribution of digital medical images across its integrated delivery ... 1984 is a nationally recognized leader in efforts to ...
Cached Biology Technology:Aurora Selects New Imaging Technology 2
(Date:8/6/2015)... and TELTOW, Germany , ... 2015 Siggraph Conference, SensoMotoric Instruments (SMI) shows ... reality , based on Epson,s Moverio BT-200 ... tracking platform. With this new solution, unprecedented quality and ... hands-free interaction with context-sensitive displays. For the first time, ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors ... growth in applications, penetration into newer sectors, and development ... The global biosensors space has seen the entry of ... market so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ... Sullivan, Analysis of the Global Biosensors Market ...
(Date:7/31/2015)... 31. juli 2015 Den 10. internationale konference ... BGI fra den 22. - 25. oktober i ... sin 10-års fødselsdag i år. Siden starten i 2006 ... møder på ,omik,-feltet, og er en af de mest ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden for ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... a common occurrence that appears over heavily forested areas around ... human activities can worsen it to the point of affecting ... to a study led by a Texas A&M University researcher. ... air chemistry for more than 20 years, says blue haze ...
... Penn., Oct. 5, 2009 Completing a major milestone in ... announced that it has sourced readers for 150 clinical trials. ... Imaging for a leading pharmaceutical company, was designed to test ... The trial used medical imaging to support the primary analysis ...
... Science Picks via e-mail, would like to change the recipient ... kcapelli@usgs.gov . October Highlights: Responding ... Climate Change, Water is Out of This World, Gender Line ... Necklace! Learn More about Bats and Rabies, Winter Warming Affects ...
Cached Biology News:Going green on hold: Man-made activities can affect 'blue haze,' world's weather 2RadMD reaches 150th clinical trial 2USGS Science Picks 2USGS Science Picks 3USGS Science Picks 4USGS Science Picks 5USGS Science Picks 6USGS Science Picks 7USGS Science Picks 8USGS Science Picks 9